This is the authors' abstract. We don't add key points for this paper.
The opportunity to observe the effect of adminis- tration of pituitary adrenocorticotrophic hormone (ACTH) and 11-dehydro-17-hydroxycorticosterone (cortisone) on the moderately active rheuma- toid arthritis of a patient with panhypopituitarism was presented us. The clinical features (1, 2) of hypopituitarism are in essence those of hypo-func- tion of the so-called "target" organs of the pitui- tary; the adrenal cortex, thyroid, and gonads. Sheehan and Summers (1) report "rheumatism of joints particularly of the knees" in 13 of 93 cases of panhypopituitarism, but elucidate no further on this clinical feature. The physiologic effects of ACTH and cortisone are well knonn (3, 4), and the dramatic response of patients with rheumatoid arthritis to these agents has been amply recorded Forsham, Thorn, Prunty, and Hills (7) noted an absence of normal initial response after administration of ACTH in the majority of cases with severe hypopituitarism, although in one case, full adrenal cortical activity was noted after six days of ACTH administration. Knowlton. Jailer, Hamilton, and West (8) reported minimal metabolic effects after administration of ACTH for 12 days in a patient with longstanding hypo- pituitarism. An increase in excretion of 17-keto- steroids and uric acid and evidence of sodium and chloride retention were the observed effects.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Schrock et al. (1951) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: